Filing Details
- Accession Number:
- 0001225208-11-019173
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-02 18:05:29
- Reporting Period:
- 2011-07-29
- Filing Date:
- 2011-08-02
- Accepted Time:
- 2011-08-02 18:05:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1204654 | C Todd Schermerhorn | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | Senior Vice President And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-07-29 | 26,720 | $66.80 | 143,708 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-07-29 | 4,384 | $99.04 | 139,324 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-07-29 | 6,149 | $97.44 | 133,175 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-07-29 | 16,187 | $98.70 | 116,988 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | Disposition | 2011-07-29 | 26,720 | $0.00 | 26,720 | $66.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 26,720 | 2015-07-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,493 | Indirect | 401(k) Plan |
Footnotes
- Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
- Represents the weighted average sales price for price increments ranging from $98.98 to $99.15. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $96.95 to $97.93. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $97.98 to $98.97. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Also granted in tandem with these options are Limited Stock Appreciation Rights which can only be exercised upon a "Change of Control" as defined in the Plan.
- Options fully vested in accordance with schedule upon achievement of certain performance criteria.
Billionaire Hedge Funds
